CARGO Therapeutics Inc. C... (CRGX)
NASDAQ: CRGX
· Real-Time Price · USD
4.54
0.08 (1.79%)
At close: Aug 15, 2025, 3:59 PM
4.54
-0.11%
After-hours: Aug 15, 2025, 04:04 PM EDT
CARGO Therapeutics Common Stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Revenue | 7.83M | 7.83M | 7.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 4.93M | 6.42M | 7.05M | 6.79M | 6.1M | 4.04M | 2.19M | 1.52M | 783K | 783K | 783K | 353K |
Gross Profit | -4.93M | -6.42M | -7.05M | -6.79M | -6.1M | -4.04M | -2.19M | -1.52M | -783K | -783K | -783K | -353K |
Operating Income | -238.57M | -234.99M | -187.37M | -172.19M | -153.79M | -122.27M | -96.71M | -72.76M | -54.1M | -36.3M | -21.05M | -10.05M |
Interest Income | 17.28M | 19M | 20.06M | 15.39M | 10.89M | 6.48M | 1.58M | 1.58M | 683K | 105K | n/a | n/a |
Pretax Income | -221.78M | -216.19M | -167.5M | -154.14M | -147.71M | -121.21M | -98.15M | -79.82M | -56.63M | -38.78M | -26.03M | -12.29M |
Net Income | -221.78M | -216.19M | -167.5M | -154.14M | -147.71M | -121.21M | -98.15M | -79.82M | -56.63M | -38.78M | -26.03M | -12.29M |
Selling & General & Admin | 41.61M | 45.18M | 43.97M | 37.54M | 29.15M | 21.15M | 13.54M | 11.11M | 9.55M | 5.69M | 3M | 1.23M |
Research & Development | 113.58M | 143.53M | 143.4M | 130.96M | 117.26M | 93.73M | 75.79M | 57.95M | 44.19M | 30.26M | 17.7M | 8.47M |
Other Expenses | 82.02M | 42.86M | -5.28M | -1.32M | 1.28M | 3.39M | 5.11M | 2.51M | -95K | -144K | -6K | n/a |
Operating Expenses | 237.21M | 231.56M | 182.09M | 167.18M | 147.69M | 118.23M | 94.52M | 71.67M | 53.74M | 35.95M | 20.7M | 9.7M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1.6M | 4.31M | 5.77M | 5.77M | 4.17M | 1.46M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 238.57M | 234.99M | 187.37M | 172.19M | 153.79M | 122.27M | 96.71M | 72.76M | 54.1M | 36.3M | 21.05M | 10.05M |
Income Tax Expense | n/a | n/a | -10K | -10K | -10K | 39K | 49K | 49K | 49K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 48.13M | 47.85M | 46.04M | 47.66M | 43.34M | 41M | 41.21M | 38.67M | 38.67M | 38.67M | 28.95M | 19.47M |
Shares Outstanding (Diluted) | 48.13M | 47.85M | 46.04M | 47.66M | 43.34M | 41M | 41.21M | 38.67M | 38.67M | 38.67M | 28.95M | 19.47M |
EPS (Basic) | -4.68 | -4.66 | -3.76 | -3.55 | -3.59 | -3.03 | -2.49 | -2.18 | -1.89 | -1.43 | -1.1 | -0.63 |
EPS (Diluted) | -4.68 | -4.66 | -3.76 | -3.55 | -3.59 | -3.03 | -2.49 | -2.18 | -1.89 | -1.43 | -1.1 | -0.63 |
EBITDA | -140.35M | -167.4M | -160.43M | -147.33M | -141.59M | -116.31M | -96.95M | -76.58M | -51.9M | -34.9M | -20.31M | -9.7M |
EBIT | -145.29M | -173.84M | -167.5M | -154.14M | -147.71M | -121.21M | -96.54M | -75.51M | -50.86M | -33.01M | -21.87M | -10.83M |
Depreciation & Amortization | 4.94M | 6.44M | 7.07M | 6.81M | 6.12M | 4.9M | 3.73M | 3.06M | 2.33M | 1.47M | 783K | 353K |